Literature DB >> 11949993

Oral contraceptives and myocardial infarction.

John Hoey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11949993      PMCID： PMC100931     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Low-dose oral contraceptive use and the risk of myocardial infarction.

Authors:  L Rosenberg; J R Palmer; R S Rao; S Shapiro
Journal:  Arch Intern Med       Date:  2001-04-23

2.  Oral contraceptive use.

Authors:  K Wilkins; H Johansen; M P Beaudet; C I Neutel
Journal:  Health Rep       Date:  2000       Impact factor: 4.796

3.  Coronary thrombosis and Conovide.

Authors:  J BOYCE; J W FAWCETT; E W NOALL
Journal:  Lancet       Date:  1963-01-12       Impact factor: 79.321

4.  Oral contraceptives and the risk of myocardial infarction.

Authors:  B C Tanis; M A van den Bosch; J M Kemmeren; V M Cats; F M Helmerhorst; A Algra; Y van der Graaf; F R Rosendaal
Journal:  N Engl J Med       Date:  2001-12-20       Impact factor: 91.245

5.  Oral contraceptives and myocardial infarction: results of the MICA case-control study.

Authors:  N Dunn; M Thorogood; B Faragher; L de Caestecker; T M MacDonald; C McCollum; S Thomas; R Mann
Journal:  BMJ       Date:  1999-06-12

6.  Oral-contraceptive use in relation to myocardial infarction.

Authors:  S Shapiro; D Slone; L Rosenberg; D W Kaufman; P D Stolley; O S Miettinen
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321
  6 in total
  1 in total

1.  Diane-35 (cyproterone acetate): safety concerns.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2003-02-18       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.